BRCC3 mutations in myeloid neoplasms

Haematologica

Volumn 100, Issue 8, 2015, Pages 1051-1057

  Huang, Dayong ^a,b   Nagata, Yasunobu ^c   Grossmann, Vera ^d   Radivoyevitch, Tomas ^e   Okuno, Yusuke ^c   Nagae, Genta ^f   Hosono, Naoko ^b   Schnittger, Susanne ^d   Sanada, Masashi ^c   Przychodzen, Bartlomiej ^b   Kon, Ayana ^c   Polprasert, Chantana ^b   Shen, Wenyi ^b   Clemente, Michael J ^b   Phillips, James G ^b   Alpermann, Tamara ^d   Yoshida, Kenichi ^c   Nadarajah, Niroshan ^d   Sekeres, Mikkael A ^b   Oakley, Kevin ^g   Nguyen, Nhu ^g   Shiraishi, Yuichi ^h   Shiozawa, Yusuke ^c   Chiba, Kenichi ^h   Tanaka, Hiroko ^h   Phillip Koeffler, H ^i,j   Klein, Hans Ulrich ^k   Dugas, Martin ^k   Aburatani, Hiroyuki ^f   Miyano, Satoru ^h   Haferlach, Claudia ^d   Kern, Wolfgang ^d   Haferlach, Torsten ^d   Du, Yang ^g   Ogawa, Seishi ^c   Makishima, Hideki ^b,c   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

^g UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^h THE UNIVERSITY OF TOKYO   (Japan)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k UNIVERSITY OF MÜNSTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; BRCA1 PROTEIN; BRCC3 PROTEIN, HUMAN; MEMBRANE PROTEIN; SMALL INTERFERING RNA;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANIMAL CELL; ARTICLE; BRCC3 GENE; COLONY FORMATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; NONSENSE MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; ALLELE; ANIMAL; CHROMOSOME ABERRATION; GENE SILENCING; GENETIC ASSOCIATION; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; NUCLEOTIDE SEQUENCE; PHENOTYPE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; ANIMALS; BRCA1 PROTEIN; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENE KNOCKDOWN TECHNIQUES; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; RNA, SMALL INTERFERING;

EID: 84938577292     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.111989     Document Type: Article

References (36)

1. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059-2074
2. Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289-2301
3. Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365(15):1384-1395
4. Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478(7367):64-69
5. Khan SN, Jankowska AM, Mahfouz R, et al. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia. 2013;27(6):1301-1309
6. Makishima H, Yoshida K, Nguyen N, et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet. 2013;45(8):942-946
7. Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616-3627
8. Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012; 366(12):1090-1098
9. Kon A, Shih LY, Minamino M, et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet. 2013;45(10):1232-1237
10. Makishima H, Visconte V, Sakaguchi H, et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. 2012;119(14):3203-3210
11. Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424-2433
12. Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368(19):1781-1790
13. Makishima H, Sugimoto Y, Szpurka H, et al. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia. 2012; 26(7):1547-1554
14. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351(6326):453-456
15. Bejar R, Stevenson K, Abdel-Wahab O, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364(26):2496-2506
16. Feng L, Wang J, Chen J. The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by two scaffold proteins localizing in different subcellular compartments. J Biol Chem. 2010;285(40):30982-30988
17. Shao G, Lilli DR, Patterson-Fortin J, Coleman KA, Morrissey DE, Greenberg RA. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13- dependent ubiquitination events at DNA double strand breaks. Proc Natl Acad Sci USA. 2009;106(9):3166-3171
18. Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004;64(19):7144-7149
19. Wu J, Liu C, Chen J, Yu X. RAP80 protein is important for genomic stability and is required for stabilizing BRCA1-A complex at DNA damage sites in vivo. J Biol Chem. 2012;287(27):22919-22926
20. Coleman KA, Greenberg RA. The BRCA1- RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem. 2011;286(15):13669-13680
21. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, Fourth Edition. Lyon: IARC Press, 2008
22. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241-247
23. Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDSderived AML. Blood. 2008;111(3):1534-1542
24. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005;65(14):6071-6079
25. Oakley K, Han Y, Vishwakarma BA, et al. Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood. 2012;119(25):6099-6108
26. Jasin M. Genetic manipulation of genomes with rare-cutting endonucleases. Trends Genet. 1996;12(6):224-228
27. Meek K, Gupta S, Ramsden DA, Lees-Miller SP. The DNA-dependent protein kinase: The director at the end. Immunol Rev. 2004; 200:132-141
28. Kakarougkas A, Jeggo PA. DNA DSB repair pathway choice: An orchestrated handover mechanism. Br J Radiol. 2014;87(1035): 20130685
29. Zheng H, Chen L, Pledger WJ, Fang J, Chen J. p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression. Oncogene. 2013;33(6):734-744
30. Song H, Hollstein M, Xu Y. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol. 2007;9(5):573-580
31. Somyajit K, Basavaraju S, Scully R, Nagaraju G. ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair. Mol Cell Biol. 2013; 33(9):1830-1844
32. Biesecker BB, Boehnke M, Calzone K, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. Jama. 1993;269(15):1970-1974
33. Narod S, Lynch H, Conway T, Watson P, Feunteun J, Lenoir G. Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet. 1993;341(8852):1101-1102
34. Li FP, Fraumeni JF Jr. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969;43(6):1365-1373
35. Vorechovsky I, Luo L, Lindblom A, et al. ATM mutations in cancer families. Cancer Res. 1996;56(18):4130-4133
36. Seiberlich V, Goldbaum O, Zhukareva V, Richter-Landsberg C. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: Implications for neurodegenerative diseases. Biochim Biophys Acta. 2012; 1823(11):2057-2068.